- Report
- August 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 195 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 192 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 193 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 191 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- December 2024
- 200 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- December 2024
- 200 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- December 2024
- 200 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- December 2024
- 200 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- December 2024
- 200 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- December 2024
- 200 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- August 2025
- 234 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- June 2025
- 215 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- January 2025
- 190 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- October 2024
- 141 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- October 2024
- 165 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- August 2025
- 224 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- July 2025
- 225 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- June 2025
- 214 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- November 2024
- 219 Pages
Global
From €2206EUR$2,500USD£1,908GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more